Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] ICFR Auditor Attestation Flag Document Financial Statement Error Correction [Flag] Auditor Firm ID Auditor Name Auditor Location First Lessor [Member] Financing Agreement [Member] Second Lessor [Member] Debt instrument face amount related party. Debt instrument unamortized discount related party. Convertible debt related party. Third Lessor [Member] Convertible debt related party current. Convertible debt related party noncurrent. Dr. Michael Ruxin [Member] Ruxin Employment Agreement [Member] Fourth Lessor [Member] Annual decretionary bonus percentage. Board of Directors [Member] 2022 Equity Incentive Plan [Member] Fifth Lessor [Member] Schedule Of Financing Right of use Assets [Table Text Block] Series C-1 Preferred Stock [Member] Investors [Member] Convertible note [Member] Securities purchase agreement [Member] Series C-2 Preferred Stock [Member] Note One [Member] Warrant one [Member] Note Two [Member] Warrant two [Member] Note Three [Member] Warrant Three [Member] Chief Medical Officer Consulting Agreement [Member] First Investors [Member] First Investors [Member] Note [Member] IMAC Holdings, Inc. [Member] Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer. Accrued interest paid. Matthew Schwartz [Member] Percentage of warrants to purchase shares. Penalty Percentage. Securities Purchase Agreement June 2022 [Member] Jeffrey Busch [Member] Demand Promissory Note Agreement [Member] Series D One Preferred Stock [Member] Amortization expense financing right of use asset. Demand Promissory Note Agreement One [Member] Schedule Of Financing Lease Liability Related To Financing Right-Of-Use Assets [Table Text Block] Financing lease payables for equipment. Financing lease payables. Payments of financing lease liabilities. Series D-2 Preferred Stock [Member] New Related Party Debentures [Member] Warrant coverage percentage. Busch Employment Agreement [Member] Working capital deficit. 2020 Equity Incentive Plan [Member] Lease Agreement [Member] Demand Promissory Notes [Member] New Related Party Debenture [Member] First Year [Member] Second year [Member] Third Year [Member] Fourth Year [Member] Fifth Year [Member] Debt instrument, default percent. Offering price percent. Lease Amendment [Member] Monthly rent, description. Securities Exchange Agreements [Member] Consultant [Member] Scientific Advisory Board Service Agreement [Member] 2022 Equity Incentive Plan [Member] Second Investor [Member] Securities Purchase Agreement Second November Two Thousand Twenty One [Member] Second November 2021 Notes [Member] Schedule Of Operating Right-Of-Use Asset [Table Text Block] Third Investor [Member] Operating Office Lease Liability. Less accumulated reduction. Schedule Of Operating Lease Liability Related To Right-Of-Use Assets [Table Text Block] Public offering description. Total lease liabilities. Reduction of operating lease liability. Licensing fees. Mr. Kucharchuk [Member] Derivative liabilities included in debt discount. Derivative liabilities included in derivative expenses. Promissory Note Agreement [Member] Pathology Advisory Board Service Agreement [Member] Debt instrument default interest rate percentage. July Investor [Member] Prepaid Asset [Policy Text Block] Share Exchange Agreement [Member] Placement Agent [Member] May 2021 Securities Purchase Agreement [Member] Securities Exchange Agreement [Member] New Debentures [Member] Accredited Investors [Member] Exchanged Convertible Notes [Member] First November 2021 Securities Purchase Agreement [Member] Beneficial conversion feature amount. Agreement description. Gunnar [Member] First April 2022 Securities Purchase Agreement [Member] Placement Agency Agreement [Member] Four Convertible Notes [Member] May 2022 Securities Purchase Agreement [Member] Exclusive License Agreement [Member] George Mason University [Member] Exchange Agreements [Member] Related party debenture and new debentures [Member] Revenue percentage. Sublicense Royalty [Member] License Agreement [Member] National Institutes of Health [Member] Non Refundable Minimum Annual Royalty. June 2022 Securities Purchase Agreement [Member] Danica Holley [Member] Vanderbilt License Agreement [Member] Relative fair value of warrant issued in connection with convertible notes recorded as debt discount. Contract Liabilities [Policy Text Block] Amortization of debt discount related to convertible notes payable. Schedule of Notes Payable Related Party [Table Text Block] Issuance of common stock in connection with conversion of series C-2 preferred stock. Issuance of common stock in connection with conversion of series C-2 preferred stock, shares Notes Payable Related Party [Member] Issuance of common stock in connection with settlement of accounts payable. Issuance of common stock in connection with settlement of accounts payable, shares. Billing and cash receipts on uncompleted contract. Douglass T Mergenthaler [Member] Subsequent Offering [Member] Issuance of common stock in connection with subscription payable. Issuance of common stock in connection with subscription payable, shares. Monthly rent description. Relative fair value of additional warrants issued in connection with modification. Relative fair value of additional warrants issued in connection with modification. Promissory Note Agreement One [Member] Two Consultants [Member] Note Agreement [Member] Notes Payable [Member] Subscription Agreement [Member] Research And Development Contract [Policy Text Block] Non Cash Lease Cost. Cash Paid during Period For Interest Abstract. Preferred Stock Dividend. Preferred Stock Dividend Two. Initial Amount of Operating Rou Asset And Related Liability. Relative Fair Value Of Warrants Issued. Relative Fair Value Of Warrants Issued. IMAC Holdings Inc Convertible Note [Member] Exchange Of Accrued Interest Payable For Convertible Debt. Exchange Of Accrued Interest Payable For Convertible Debt Related Parties. Exchange Of Preferred Stock And Accrued Dividends For Convertible Debt Related Parties. Recorded Debt Discount. Initial Fair Value Of Derivative Liabilities. Customer One [Member] Customer Two [Member] Customer Three [Member] Customer Four [Member] Acts Effective Date [Member] IMAC [Member] IMAC Holdings Inc Promissory Note [Member] Repayment of interest Customer [Member] Deferred Revenue [Member] Related Parties [Policy Text Block] Convertible note principal related party. First November 2021 [Member] Second November 2021 [Member] Third November 2021 [Member] Amarantus BioScience Holdings, Inc. [Member] First January 2022 [Member] Second January 2022 [Member] Debt instrument unamortized discount notes related party. First April 2022 [Member] Second April 2022 [Member] May 2022 [Member] June 2022 [Member] July 2022 [Member] First November Two Thousand And Twenty One [Member] Current Exercise Price [Member] New Exercise Price [Member] Second November Two Thousand And Twenty One [Member] Share based compensation arrangement by share based payment award non option equity instruments warrants issued in connection with issued in connection with A new related party debentures. Laboratory equipment. Laboratory Equipment [Member] Purchase Agreement [Member] Share based compensation arrangement by share based payment award non option equity instruments warrants issued in connection with issued in connection with A new debentures. Non option equity issued to placement agent and consultant with new related party debentures weighted average granted. The number of shares into which fully or partially vestednon-option equity outstanding as of the balance sheet date can be currently converted under the non-option equity plan. Agreement and Plan of Merger [Text Block] Weighted average price at which grantees can acquire the shares reserved for issuance under the stock non-option equity plan. Non option equity issued with new related party debentures weighted average granted. Non option equity in connection with new debentures weighted average granted. Non option equity issued to placement agent and consultant with new related party debentures. The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of non-option equity outstanding and currently exercisable under the non-option equity plan. Non option equity outstanding weighted average remaining contractual term. Weighted average remaining contractual term for vested portions of non-option equity outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Share based payment award non options outstanding intrinsic value balance. Sharebased compensation arrangement by sharebased payment award non options exercisable intrinsic value. Share based compensation arrangement by share based payment award options outstanding exercise price. Consulting Agreement [Member] First And Second January Two Thousand Twenty Two [Member] Issued in connection with a convertible debt – related party. Issued in connection with a convertible debt – related party. Issued in connection with a convertible debt – related party. Issued in connection with a convertible debt. Issued in connection with a New Related Party Convertible Debentures. Issued in connection with a convertible debt. Minimum Smallest [Member] Convertible Secured Promissory Note [Member] IMAC Note Agreement [Member] Contingent conversion accrued interest. Dr Ruxin [Member] Consulting fees. Thomas e chilcott three [Member] Offer Letter [Member] Zaslavsky [Member] Base salary percentage. Mr Chilcott [Member] Second Demand Promissory Note Agreement One [Member] Promissory Note Agreement Douglas [Member] Promissory Note Agreement IMAC Holdings Inc [Member] Promissory Note Agreement Jeffrey Busch [Member] Cash FDIC insured amount limit Biopharma Services [Member[ Patient Testing Service [Member] IMAC Convertible Secured Note [Member] Operating right of use asset and lease liability. Percentage of debentures interest and liquidated value.